A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic Stroke
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBeijing Tiantan Hospital
About this trial
This study aims to construct a registry platform for microcirculatory disorders in a large sample of Chinese patients with cerebral small vessel disease and ischemic stroke; To explore the role of microcirculatory disorders in different types of cerebral small vessel disease and iachemic stroke, as well as their pathogenesis, severity, and prognosis; And to research on the drug treatment of microcirculatory disorders for cerebral small vessel disease and stroke in the real world.
Eligibility criteria
Qualifiers
Age ≥ 18 years old.
Acute ischemic stroke within 7 days of onset.
Sign an informed consent form.
Age ≥ 18 years old.
Disqualifiers
Cerebral hemorrhage and subarachnoid hemorrhage within 3 months of onset.
There are untreated cerebral vascular malformations or untreated aneurysms (diameter>3mm).
Confirmed neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Parkinson's syndrome, etc.
A mental illness diagnosed according to the DSM-V diagnostic criteria.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
20,000 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov